世界のポジティブ・アロステリック・モジュレーター市場予測（～2028年）：ベンゾジアゼピン、バルビツール酸塩、アマンタジン、その他

• 英文タイトル：Global Positive Allosteric Modulators Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

• レポートコード：GIR-22E8940 • 出版社/出版日：GlobalInfoResearch / 2022年5月 • レポート形態：英文、PDF、99ページ • 納品方法：Eメール（2~3営業日） • 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥504,600 (USD3,480)	▷ お問い合わせ
Multi User	￥756,900 (USD5,220)	▷ お問い合わせ
Corporate User	￥1,009,200 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

ポジティブ・アロステリック・モジュレーター市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。 GlobalInfoResearchの最新の調査によると、世界のポジティブ・アロステリック・モジュレーターの市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。 ポジティブ・アロステリック・モジュレーター市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。 種類別セグメントは次をカバーします。 ・ベンゾジアゼピン、バルビツール酸塩、アマンタジン、その他 用途別セグメントは次のように区分されます。 ・パーキンソン病、統合失調症、アルツハイマー病 世界のポジティブ・アロステリック・モジュレーター市場の主要な市場プレーヤーは以下のとおりです。 ・F. Hoffmann-La Roche、Pfizer、Taj Pharmaceuticals、Explicit Chemicals、Shaanxi Rebecca Bio-Tech、Zydus Cadila、ACADIA Pharmaceuticals、M Somerset Pharmaceuticals、Vertical Pharmaceuticals 地域別セグメントは次の地域・国をカバーします。 ・北米（米国、カナダ、メキシコ） ・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア） ・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア） ・南アメリカ（ブラジル、アルゼンチン、コロンビア） ・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ） 本調査レポートの内容は計15章あります。 ・第1章では、ポジティブ・アロステリック・モジュレーター製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。 ・第2章では、主要なポジティブ・アロステリック・モジュレーターメーカーの企業概要、2019年～2022年までのポジティブ・アロステリック・モジュレーターの価格、販売量、売上、市場シェアを掲載しています。 ・第3章では、主要なポジティブ・アロステリック・モジュレーターメーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。 ・第4章では、2017年～2028年までの地域別ポジティブ・アロステリック・モジュレーターの販売量、売上、成長性を示しています。 ・第5、6章では、2017年～2028年までのポジティブ・アロステリック・モジュレーターの種類別と用途別の市場規模、市場シェアと成長率を掲載しています。 ・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域でのポジティブ・アロステリック・モジュレーター市場予測を収録しています。 ・第12章では、主要な原材料、主要なサプライヤー、およびポジティブ・アロステリック・モジュレーターの産業チェーンを掲載しています。 ・第13、14、15章では、ポジティブ・アロステリック・モジュレーターの販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。 ***** 目次(一部) ***** ・市場概要 ・メーカー情報（企業概要、製品概要、販売量、価格、売上）：F. Hoffmann-La Roche、Pfizer、Taj Pharmaceuticals、Explicit Chemicals、Shaanxi Rebecca Bio-Tech、Zydus Cadila、ACADIA Pharmaceuticals、M Somerset Pharmaceuticals、Vertical Pharmaceuticals ・メーカー別市場シェア ・地域別市場分析2017年-2028年 ・種類別分析2017年-2028年：ベンゾジアゼピン、バルビツール酸塩、アマンタジン、その他 ・用途別分析2017年-2028年：パーキンソン病、統合失調症、アルツハイマー病 ・ポジティブ・アロステリック・モジュレーターの北米市場規模2017年-2028年：アメリカ、カナダ、メキシコ ・ポジティブ・アロステリック・モジュレーターのヨーロッパ市場規模2017年-2028年：ドイツ、イギリス、フランス、ロシア、イタリア ・ポジティブ・アロステリック・モジュレーターのアジア市場規模2017年-2028年：中国、日本、韓国、インド、東南アジア、オーストラリア ・ポジティブ・アロステリック・モジュレーターの南米市場規模2017年-2028年：ブラジル、アルゼンチン ・ポジティブ・アロステリック・モジュレーターの中東・アフリカ市場規模2017年-2028年：サウジアラビア、トルコ、エジプト、南アフリカ ・原材料および産業チェーン ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論

The Positive Allosteric Modulators market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Positive Allosteric Modulators market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during forecast period 2022-2028. Parkinson’s Disease accounting for % of the Positive Allosteric Modulators global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Benzodiazepines segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Positive Allosteric Modulators include F. Hoffmann-La Roche, Pfizer, Taj Pharmaceuticals, Explicit Chemicals, and Shaanxi Rebecca Bio-Tech, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Positive Allosteric Modulators market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Benzodiazepines
Barbiturates
Amantadine
Other
Market segment by Application can be divided into
Parkinson’s Disease
Schizophrenia
Alzheimer’s Disease
The key market players for global Positive Allosteric Modulators market are listed below:
F. Hoffmann-La Roche
Pfizer
Taj Pharmaceuticals
Explicit Chemicals
Shaanxi Rebecca Bio-Tech
Zydus Cadila
ACADIA Pharmaceuticals
M Somerset Pharmaceuticals
Vertical Pharmaceuticals
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Positive Allosteric Modulators product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Positive Allosteric Modulators, with price, sales, revenue and global market share of Positive Allosteric Modulators from 2019 to 2022.
Chapter 3, the Positive Allosteric Modulators competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Positive Allosteric Modulators breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Positive Allosteric Modulators market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Positive Allosteric Modulators.
Chapter 13, 14, and 15, to describe Positive Allosteric Modulators sales channel, distributors, customers, research findings and conclusion, appendix and data source.

レポート目次

---

1 Market Overview
1.1 Positive Allosteric Modulators Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Positive Allosteric Modulators Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Benzodiazepines
1.2.3 Barbiturates
1.2.4 Amantadine
1.2.5 Other
1.3 Market Analysis by Application
1.3.1 Overview: Global Positive Allosteric Modulators Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Parkinson’s Disease
1.3.3 Schizophrenia
1.3.4 Alzheimer’s Disease
1.4 Global Positive Allosteric Modulators Market Size & Forecast
1.4.1 Global Positive Allosteric Modulators Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Positive Allosteric Modulators Sales in Volume (2017-2028)
1.4.3 Global Positive Allosteric Modulators Price (2017-2028)
1.5 Global Positive Allosteric Modulators Production Capacity Analysis
1.5.1 Global Positive Allosteric Modulators Total Production Capacity (2017-2028)
1.5.2 Global Positive Allosteric Modulators Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Positive Allosteric Modulators Market Drivers
1.6.2 Positive Allosteric Modulators Market Restraints
1.6.3 Positive Allosteric Modulators Trends Analysis
2 Manufacturers Profiles
2.1 F. Hoffmann-La Roche
2.1.1 F. Hoffmann-La Roche Details
2.1.2 F. Hoffmann-La Roche Major Business
2.1.3 F. Hoffmann-La Roche Positive Allosteric Modulators Product and Services
2.1.4 F. Hoffmann-La Roche Positive Allosteric Modulators Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Pfizer
2.2.1 Pfizer Details
2.2.2 Pfizer Major Business
2.2.3 Pfizer Positive Allosteric Modulators Product and Services
2.2.4 Pfizer Positive Allosteric Modulators Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Taj Pharmaceuticals
2.3.1 Taj Pharmaceuticals Details
2.3.2 Taj Pharmaceuticals Major Business
2.3.3 Taj Pharmaceuticals Positive Allosteric Modulators Product and Services
2.3.4 Taj Pharmaceuticals Positive Allosteric Modulators Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Explicit Chemicals
2.4.1 Explicit Chemicals Details
2.4.2 Explicit Chemicals Major Business
2.4.3 Explicit Chemicals Positive Allosteric Modulators Product and Services
2.4.4 Explicit Chemicals Positive Allosteric Modulators Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Shaanxi Rebecca Bio-Tech
2.5.1 Shaanxi Rebecca Bio-Tech Details
2.5.2 Shaanxi Rebecca Bio-Tech Major Business
2.5.3 Shaanxi Rebecca Bio-Tech Positive Allosteric Modulators Product and Services
2.5.4 Shaanxi Rebecca Bio-Tech Positive Allosteric Modulators Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Zydus Cadila
2.6.1 Zydus Cadila Details
2.6.2 Zydus Cadila Major Business
2.6.3 Zydus Cadila Positive Allosteric Modulators Product and Services
2.6.4 Zydus Cadila Positive Allosteric Modulators Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 ACADIA Pharmaceuticals
2.7.1 ACADIA Pharmaceuticals Details
2.7.2 ACADIA Pharmaceuticals Major Business
2.7.3 ACADIA Pharmaceuticals Positive Allosteric Modulators Product and Services
2.7.4 ACADIA Pharmaceuticals Positive Allosteric Modulators Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 M Somerset Pharmaceuticals
2.8.1 M Somerset Pharmaceuticals Details
2.8.2 M Somerset Pharmaceuticals Major Business
2.8.3 M Somerset Pharmaceuticals Positive Allosteric Modulators Product and Services
2.8.4 M Somerset Pharmaceuticals Positive Allosteric Modulators Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Vertical Pharmaceuticals
2.9.1 Vertical Pharmaceuticals Details
2.9.2 Vertical Pharmaceuticals Major Business
2.9.3 Vertical Pharmaceuticals Positive Allosteric Modulators Product and Services
2.9.4 Vertical Pharmaceuticals Positive Allosteric Modulators Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Positive Allosteric Modulators Breakdown Data by Manufacturer
3.1 Global Positive Allosteric Modulators Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Positive Allosteric Modulators Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Positive Allosteric Modulators
3.4 Market Concentration Rate
3.4.1 Top 3 Positive Allosteric Modulators Manufacturer Market Share in 2021
3.4.2 Top 6 Positive Allosteric Modulators Manufacturer Market Share in 2021
3.5 Global Positive Allosteric Modulators Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Positive Allosteric Modulators Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Positive Allosteric Modulators Market Size by Region
4.1.1 Global Positive Allosteric Modulators Sales in Volume by Region (2017-2028)
4.1.2 Global Positive Allosteric Modulators Revenue by Region (2017-2028)
4.2 North America Positive Allosteric Modulators Revenue (2017-2028)
4.3 Europe Positive Allosteric Modulators Revenue (2017-2028)
4.4 Asia-Pacific Positive Allosteric Modulators Revenue (2017-2028)
4.5 South America Positive Allosteric Modulators Revenue (2017-2028)
4.6 Middle East and Africa Positive Allosteric Modulators Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Positive Allosteric Modulators Sales in Volume by Type (2017-2028)
5.2 Global Positive Allosteric Modulators Revenue by Type (2017-2028)
5.3 Global Positive Allosteric Modulators Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Positive Allosteric Modulators Sales in Volume by Application (2017-2028)
6.2 Global Positive Allosteric Modulators Revenue by Application (2017-2028)
6.3 Global Positive Allosteric Modulators Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Positive Allosteric Modulators Sales by Type (2017-2028)
7.2 North America Positive Allosteric Modulators Sales by Application (2017-2028)
7.3 North America Positive Allosteric Modulators Market Size by Country
7.3.1 North America Positive Allosteric Modulators Sales in Volume by Country (2017-2028)
7.3.2 North America Positive Allosteric Modulators Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Positive Allosteric Modulators Sales by Type (2017-2028)
8.2 Europe Positive Allosteric Modulators Sales by Application (2017-2028)
8.3 Europe Positive Allosteric Modulators Market Size by Country
8.3.1 Europe Positive Allosteric Modulators Sales in Volume by Country (2017-2028)
8.3.2 Europe Positive Allosteric Modulators Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Positive Allosteric Modulators Sales by Type (2017-2028)
9.2 Asia-Pacific Positive Allosteric Modulators Sales by Application (2017-2028)
9.3 Asia-Pacific Positive Allosteric Modulators Market Size by Region
9.3.1 Asia-Pacific Positive Allosteric Modulators Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Positive Allosteric Modulators Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Positive Allosteric Modulators Sales by Type (2017-2028)
10.2 South America Positive Allosteric Modulators Sales by Application (2017-2028)
10.3 South America Positive Allosteric Modulators Market Size by Country
10.3.1 South America Positive Allosteric Modulators Sales in Volume by Country (2017-2028)
10.3.2 South America Positive Allosteric Modulators Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Positive Allosteric Modulators Sales by Type (2017-2028)
11.2 Middle East & Africa Positive Allosteric Modulators Sales by Application (2017-2028)
11.3 Middle East & Africa Positive Allosteric Modulators Market Size by Country
11.3.1 Middle East & Africa Positive Allosteric Modulators Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Positive Allosteric Modulators Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Positive Allosteric Modulators and Key Manufacturers
12.2 Manufacturing Costs Percentage of Positive Allosteric Modulators
12.3 Positive Allosteric Modulators Production Process
12.4 Positive Allosteric Modulators Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Positive Allosteric Modulators Typical Distributors
13.3 Positive Allosteric Modulators Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

---